Jessica Strzepka Profile
Jessica Strzepka

@GIJessMD

Followers
87
Following
116
Media
7
Statuses
22

GI fellow @Rush_GI | @RushDOIM | @uiccom ‘20 | @Illinois_Alumni ‘16

Chicago, IL
Joined May 2022
Don't wanna be here? Send us removal request.
@GIJessMD
Jessica Strzepka
3 years
So much fun at my first DDW! Grateful for the opportunity to share my research and learn from leaders in the field. Looking forward to next year already! @DDWMeeting @AmerGastroAssn @RushMedical @RushDOIM
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
2
6
@GIJessMD
Jessica Strzepka
3 months
Thank you to the Cook County GI fellowship program for inviting @Rush_GI to attend their @AmCollegeGastro visiting professorship with @RenaYadlapati of @UCSD_GI! . Such a fun & educational day learning all things esophageal motility from a leader in the field!👏🏻. @CookCountyIMR
Tweet media one
1
4
39
@GIJessMD
Jessica Strzepka
1 year
RT @Rush_GI: 🚨‼️Be sure to sign up for our “updates on pancreaticobiliary endoscopy” course: next Friday, August 9th! Looking forward to a….
0
1
0
@GIJessMD
Jessica Strzepka
1 year
Such an inspiring WHISE leadership forum today at @CLDFoundation’s 4th annual Liver Connect conference! Perfect end to a great conference weekend! @NancyReau
Tweet media one
0
1
2
@GIJessMD
Jessica Strzepka
2 years
Great time working with Community Empowerment in the Dominican Republic this past week! @RushMedical @RushDOIM
Tweet media one
Tweet media two
Tweet media three
0
0
7
@GIJessMD
Jessica Strzepka
2 years
Hep B/C in women/🤰@TatyanaKushner WHO 🌎 health strat (‘22-‘23): goal to ⬆️ vax, dec vertical transmission (⬆️ risk with ⬆️ viral load, HCV/HIV coinfxn, ⬇️access/knowledge/policies). ⬆️ data for HCV tx in 🤰upcoming. 4.5 mil HBV and 0.1-4.1% HCV births annually (⬆️ w geo/IVDU).
0
1
2
@GIJessMD
Jessica Strzepka
2 years
Pregnancy Guidelines by @AniKardashianMD ➡️intrahepatic cholestasis of pregnancy: most common gestational 🤰liver disease. Universal HCV screening guidelines= ⬆️ ➕ rates (need more antiviral tx safety data in preg). ASA ppx for preeclampsia🟰variable recs/data.
1
0
1
@GIJessMD
Jessica Strzepka
2 years
Women & EtOH use, Dr Jessica Leigh Mellinger: ⬆️ rates in EtOH use ➡️ driven by women. D/t: feminization of EtOH, “self care” 🍷🍸🍹. ⬆️ risk of cirrhosis in women w ANY amt of EtOH use. <40 yo F w ⬆️ posttransplant mortality. NO quick fix- need multifactorial tx approach 🔀.
1
0
1
@GIJessMD
Jessica Strzepka
2 years
🤰& portal HTN by @NancyReau: ⬆️ rates of chronic liver disease in women of childbearing age (10➡️25%). Fertility NOT affected in compensated cirrhosis pts. ⬆️ risk preeclampsia/preterm birth. AASLD: EV screen (18-20% maternal mortality) 12 mos preconception (NSBB OK in 🤰).
1
0
1
@GIJessMD
Jessica Strzepka
2 years
PBC/AIH in minority women by @lilydaramd: early studies DON’T look at race/ethnicity➡️modern era w/⬆️ awareness. AIH: black pts present younger w/ more adv fibrosis. PBC: Latinx pts present at adv stages w/ more variant/overlap dz. Need: ⬆️ access to care, diversity of care team.
2
1
2
@GIJessMD
Jessica Strzepka
2 years
Sex Diff in Liver Cancer by Dr Nicole Rich: gap in M>F HCC prevalence is ⬇️; overview of sex hormone hypothesis & female ⬇️ in liver Ca trials. ⬆️ burden of NAFLD-HCC in women. Early diagnosis/screening🟰imp for survival, however women w/ cirrhosis often unrecognized.
1
0
1
@GIJessMD
Jessica Strzepka
2 years
Sex diff & drug research/development by @TramTran_MD: ➡️decades of work to incorporate females into trials ➡️consider pharm metabolism differences between sexes ➡️CV research as model for studying sex diff ➡️liver accounts for expression of 72% of sexually differentiated genes.
1
0
0
@GIJessMD
Jessica Strzepka
2 years
NAFLD/NASH & Women by Dr Nadege Gunne: ⬇️ data available for F, ⬆️ risk for depression in NAFLD/NASH for F>M (as high as 44%!), sexual differences in pathophys (⬆️ risk post menopause), ⬆️ risk of death for women on transplant list.
1
0
0
@GIJessMD
Jessica Strzepka
2 years
So excited to be attending the CLDF Liver Connect conference in Huntington Beach, CA and seeing the WHISE (Women in Hepatology, Initiatives, Sponsorship & Empowerment) “Filling the gender gaps in liver disease” session come together!👇 highlights from our speakers @CLDFoundation.
1
0
8
@GIJessMD
Jessica Strzepka
3 years
RT @NancyReau: 🚨We are now accepting abstract submissions for #RushIntoGI: An Update in Gastroenterology & Hepatology 🚨. 🔹Submission Deadli….
0
1
0
@GIJessMD
Jessica Strzepka
3 years
RT @ManaviBhagwat: Thanks to @RushDOIM PGY-3 @JessStrzepkaMD for this great talk on PPI use in cirrhosis! Long term PPI use assoc. w/ incre….
0
2
0
@GIJessMD
Jessica Strzepka
3 years
Great first day at #ACG2022 enjoying the postgraduate course! @ManaviBhagwat @BSchwartzMD @TaviaBuysseMD @AmCollegeGastro @RushDOIM @RushIMChiefs
Tweet media one
0
3
17
@GIJessMD
Jessica Strzepka
3 years
Congratulations to @plrabin for an excellent oral presentation on our POCUS course research at #CHEST2022 Excited for the first session of this year’s course in our SIM center today! @Rushpulmcc @RushDOIM @RushIMChiefs @accpchest
Tweet media one
0
3
10
@GIJessMD
Jessica Strzepka
3 years
RT @NancyReau: 🎈 Congratulations to @JessStrzepkaMD of @RushDOIM on a fantastic poster for the #DeltaCure Meeting!🎈. #livertwitter https:….
0
2
0
@GIJessMD
Jessica Strzepka
3 years
An incredible experience and opportunity to attend and present at the first annual #DeltaCure conference! With an excellent presentation by @NancyReau on the epidemiology of #HDV in North America. So great to hear and learn from experts around the 🌎! @RushDOIM @RushMedical
Tweet media one
Tweet media two
0
0
8